文献速递胸部MRCT

肺癌筛查中的MRI:前两轮筛查中基于LDCT与MRI的Lung-RADS分类比较评估

Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
PubMed 文献 · Eur Radiol · 2018-07-10

本研究对224名肺癌筛查参与者行MRI与低剂量CT(LDCT)检查,MRI序列包括T2、平衡、T1和DWI。MRI与LDCT的Lung-RADS评分显著相关,且MRI未漏诊或低估任何Lung-RADS 3分及以上的相关发现。作者认为Lung-RADS可能适用于MRI肺癌筛查。

要点

  • MRI与LDCT的Lung-RADS评分显著相关,MRI未漏诊或低估任何Lung-RADS 3分及以上病灶。
  • MRI对Lung-RADS 4A高估1例、3类高估2例、2类高估5例,对1类低估20例。
  • 8例肺癌均被MRI准确显示,早期召回率从基线13.8%降至第二轮1.9%。

核心结论

  • Lung-RADS可能适用于MRI肺癌筛查,因为MRI表现与LDCT相关,且MRI从未漏诊或低估Lung-RADS 3分及以上的相关发现。

研究设计与样本

  • 肺癌筛查研究,224名参与者,均行MRI与低剂量CT(LDCT)检查,MRI序列为T2、平衡、T1和DWI,以LDCT为参考标准。

关键影像表现/征象

  • MRI序列包括T2、平衡、T1和DWI,最小结节大小为4mm。
  • MRI准确显示全部8例肺癌。
  • MRI与LDCT的Lung-RADS评分显著相关。

诊断标准与关键数值

  • MRI与LDCT的Lung-RADS分类结果(括号内为LDCT):4B/4X 10例(10例),4A 16例(15例),3类13例(12例),2类77例(92例),1类140例(126例)。
  • MRI高估评分:4A类1例,3类2例,2类5例;MRI低估评分:1类20例。
  • 早期召回率从基线13.8%降至第二轮筛查1.9%,活检率第一轮3.6%、第二轮0.5%。
  • 9名接受活检/手术的参与者中组织学证实肺癌8例。

临床应用与阅片要点

  • 阅片时注意MRI对Lung-RADS 1类可能存在低估(20例),对2类、3类和4A类可能存在高估。
  • Lung-RADS 3分及以上病灶在MRI上未被漏诊或低估,可据此进行随访管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate MRI for lung cancer screening comparing LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.

MATERIALS AND METHODS: 224 participants in a lung cancer screening study were examined with MRI and low-dose CT (LDCT). Acquired MRI sequences were T2, balanced, T1 and DWI. MRI was prospectively analysed regarding nodules. Minimum nodule size was 4 mm. Nodules were assigned a Lung-RADS score based on appearance and size at baseline and after 3, 6 and 12 months. MRI findings were correlated with LDCT.

RESULTS: The early recall rate dropped from 13.8% at baseline to 1.9% in the second screening round with biopsy rates of 3.6% in the first round and 0.5% in the second round. Histology revealed lung cancer in 8/9 participants undergoing biopsy/surgery. All eight cancers were accurately depicted by MRI. The following categories were assigned on MRI (results of LDCT in parentheses): 4B/4X in 10 (10) cases, 4A in 16 (15) cases, 3 in 13 (12) cases, 2 in 77 (92) cases and 1 in 140 (126) cases. Lung-RADS scoring correlated significantly between MRI and CT. The score was overestimated by MRI in one case for category 4A, in two cases for category 3 and in five cases for category 2. MRI-based Lung-RADS score was underestimated for category 1 in 20 cases.

CONCLUSION: Lung-RADS might be applied for lung cancer screening with MRI, since findings correlated with LDCT. Relevant findings with a Lung-RADS score of 3 and higher were never missed or underestimated by MRI KEY POINTS: • MRI performed comparably to low-dose CT in a lung cancer-screening programme. • Lung-RADS might be applied for lung cancer screening with MRI. • Lung-RADS findings score of 3 and higher were never missed by MRI.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Meier-Schroers M, Homsi R, Gieseke J, et al. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds. Eur Radiol. 2018. PMID: 29992387. doi:10.1007/s00330-018-5607-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。